US WorldMeds
KY - LouisvillePharmaceutical
Focus: US WorldMeds is a public specialty pharmaceutical company focused on neurology and addiction medicine, headquartered in Louisville, KY with a pipeline-driven business model.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
12+9 this month
Growing — net +9 jobs in 30d
14 jobs added vs 5 removed. Steady team buildout.
Should You Work at US WorldMeds?
AI assessmentSuitable for mission-driven pharma professionals willing to accept pipeline uncertainty in exchange for exposure to specialized neurology and addiction therapeutics; recommend vetting financial stability before committing.
Why Work Here
- Diversified pipeline across high-need therapeutic areas including opioid addiction (FDA-approved LUCEMYRA) and oncology immunotherapy with 32 active trials
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth
FDA-approved treatment for opioid withdrawal; core marketed product with active Phase 4 trial ongoing.
Pipeline & Clinical Trials
Help build intelligence for US WorldMeds
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.